Pfizer Vaccine Contract Australia

Pfizer Vaccine Contract Australia: All You Need to Know

Since the outbreak of the COVID-19 pandemic, the world has been eagerly awaiting vaccines that can help control the spread of the virus. Among the vaccines that have been authorized for use is the one developed by Pfizer-BioNTech. In Australia, the government has signed a contract with Pfizer for the supply of this vaccine, which brings hope to the Australian population that the pandemic can be brought under control. In this article, we will look at the key details of the Pfizer vaccine contract in Australia.

What is the Pfizer vaccine?

The Pfizer-BioNTech COVID-19 vaccine, also known as BNT162b2, is a messenger RNA (mRNA) vaccine. It works by teaching the body how to produce proteins that are part of the SARS-CoV-2 virus, which causes COVID-19. The immune system then recognizes these proteins as foreign and produces antibodies to fight them. If the person vaccinated later comes into contact with the actual virus, their immune system is already prepared to fight it.

What is the Pfizer vaccine contract in Australia?

In November 2020, the Australian Government signed a contract with Pfizer for the supply of 10 million doses of its COVID-19 vaccine. The agreement was made with Pfizer Australia, a subsidiary of Pfizer, and is part of the Australian Government`s vaccine strategy to protect the population against the virus.

Under the contract, Pfizer agreed to provide the doses in stages, with the first shipments arriving in Australia in early 2021. The doses are expected to be administered to priority groups, including aged care residents and workers, healthcare workers, and quarantine and border workers, among others.

The contract also includes an option for the Australian Government to purchase an additional 20 million doses of the Pfizer vaccine, subject to its approval by the Therapeutic Goods Administration (TGA). If the option is exercised, it would bring the total number of doses to 30 million, enough to vaccinate the entire Australian population.

What are the benefits of the Pfizer vaccine contract in Australia?

The Pfizer vaccine contract offers several benefits to the Australian population. Firstly, the vaccine has been shown in clinical trials to be highly effective in preventing COVID-19, with an efficacy rate of around 95%. This means that it can significantly reduce the chance of getting infected with the virus, which is especially important for those who are at higher risk of severe illness or death.

Secondly, the contract represents a significant step towards ending the pandemic in Australia. Vaccination is a crucial part of the strategy to control the spread of the virus, alongside measures such as social distancing and wearing masks. With the Pfizer vaccine, Australia can start vaccinating its population and move towards herd immunity, where enough people have immunity against the virus to prevent its further spread.

Finally, the Pfizer vaccine contract is a testament to the Australian Government`s commitment to protecting its citizens against the COVID-19 pandemic. By signing the contract, the government has taken a proactive approach to securing a safe and effective vaccine for its population.


The Pfizer vaccine contract in Australia marks a significant milestone in the fight against the COVID-19 pandemic. With the supply of 10 million doses of the Pfizer-BioNTech vaccine, Australia can start vaccinating its population and move towards ending the pandemic. The contract offers hope to Australians that the worst of the pandemic is behind us, and that there is light at the end of the tunnel. As the vaccine is rolled out, it is essential that Australians continue to adhere to public health measures to help keep themselves and their communities safe.